Type I NK T-cells, also called invariant NK T-cells, mediated the secretion of IFN-γ and TNF-α that improves antitumor effect and IL-4, IL-10, and IL-13 modulating tumor niche (139). The gene discussed is IFNG; the disease is neoplasm.